ABSTRACT X-ray analysis at 3.2-A resolution revealed that the Mcg IgGl (A chain) immunoglobulin is a compact T-shaped molecule. Because of the hinge deletion, the Fc fragment lobe is pulled tightly upward into the junction of the Fab arms. Along the molecular twofold axis, the Fab arms are joined by an interchain disulfide bond between the two light chains. The antigen combining sites consist of large irregular cavities at the tips of the Fab regions. Potential complement (Clq) binding sites on Fc are sterically shielded by the Fab arms, but putative attachment sites are accessible for docking with the FcRI receptor on human monocytes and with protein A of Staphylococcus aureus.
Progress in the elucidation of three-dimensional structures of intact antibodies has been slow for two principal reasons. (i) Supplies of crystalline proteins have been limited, and (ii) the Fc units have been disordered in crystals of immunoglobulins containing hinge regions. Like Mcg (1) (2) (3) (4) , the Dob IgGl protein has a hinge deletion (5) and an Fc region that appears to be ordered in the crystal lattice (6) . In the Kol IgGl, the Fc is disordered, but the structures of the Fab arms and the hinge region are well defined (7, 8) . Similarly, a comparison of the Zie IgG2 molecule and its F(ab)2 fragment indicated that the Fc does not contribute significantly to the diffraction pattern of the intact IgG2 protein (9) .
The absence of a hinge region is associated with a substantial loss of segmental flexibility in an antibody molecule (10) (11) (12) (13) . Such a protein is more compact in solution, since sedimentation coefficients increase as hinge regions become shorter (13, 14) . Hinge deletions are also accompanied by alterations (or abrogation) of important effector functions such as complement fixation and attachment to cellular receptors (1, 2, 11-20; J. M. Woof and D. R. Burton as quoted in ref. 21) .
Unlike most IgGs, the Mcg protein is a euglobulin that can be crystallized by dialysis against deionized water (3) . In an earlier study (4) , the crystal structure was determined at 6.5-A resolution by the multiple isomorphous replacement (MIR) method with five heavy-atom derivatives. Individual domains from known structures of human immunoglobulin fragments (8, (22) (23) (24) (25) were fitted into the low-resolution map with the program SEARCH (6) . Attempts to fit domains in pairs-e.g., variable region light and heavy chain (VL-VH) or constant region light and heavy chain (CL-CH1) pairs-were not very successful because the quaternary structures in Mcg were different from those in Fab fragments (8, 22) , Fc fragments (24) , and the Dob immunoglobulin (6 Table 1 ).
With diffractometer data from 8-to 3.5-A (5132 reflections, 46% complete), the MIR model was previously refined in stages to an R factor of 28% with the program PROLSQ (26) . The amino acid sequence of the light chain was provided by Fett and Deutsch (27) . D. C. Shaw (personal communication) determined the sequences ofresidues 1-69 and 109-117 ofthe VH domain. The remaining residues in VH and in the three CH domains were assigned sequences by comparisons with similar heavy chains (28) .
Data from the diffractometer were replaced with the area detector set, and the refinement was continued by the procedure outlined in Table 2 . X-PLOR (29) was used for rigidbody refinement, first with the Fab and Fc regions treated as intact units and then with six individual domains. The R factor for the 10-to 4-A set (99% complete) was 46.9%. Small rotations and translations from their starting positions were noted for all domains, but especially for CL. X-PLOR was next used for positional refinement (600 cycles) and simulated annealing ("slow-cooling" protocol) with 10-to 3.5-A data. To reduce the effects of model bias, the three complementarity-determining regions (CDR) of the heavy chain, the segment connecting the CH2 and CH3 domains, and the carbohydrate were not included in the model used for the initial stage of positional refinement. These segments were then located by difference Fourier analyses and added to the model. As a further precaution, the structures of these segments were rebuilt after calculation of "annealed omit" maps (29 *Rmerge is the unweighted-squared R factor on intensity x 100.
To complete the procedure, cycles of refinement were alternated with interactive model building on a Silicon GraphiCS IRIS 4D/80GT graphics workstation with the program TURBO-FRODO (30, 31) . Fo -Fc OMIT maps (32) were calculated with 20 of 642 residues deleted at each step until the entire asymmetric unit was examined and rebuilt as necessary. Dihedral angles were checked with "Ramachandran plots" (31) . Residues with and qi angles outside the prescribed boundaries were refitted and subjected to additional refinement cycles. Currently, the R factors are 21.5% at 3.5-A and 23.2% at 3.2-A resolution. Root-mean-square (rms) deviations from ideal values are 0.022 and 0.027 A for bond lengths and angles.
Molecular Replacement Methods. An attempt was made to solve the structure independently by molecular replacement methods (33) (34) (35) . Rotation, translation, and correlation functions were calculated with the programs MERLOT (33) and RTMAP (35) with 8-to 4-or 6-to 4-A data. VL-VH, CL-CH1 and CH2-CH3 pairs of domains from the Kol and New Fabs (8, 22) and the human Fc (24) (Table 2) , the polypeptide chains could be traced throughout their lengths, and >95% of the side chains could be fitted to the electron density. To illustrate the quality ofthe maps, a stereo diagram of "cage" electron density for a light chain segment (residues 30-36) is presented with a superimposed skeletal model in Fig. 1 .
As an independent approach to the structural analysis, molecular replacement techniques were not effective with canonical pairs of domains as starting models. Among singledomain probes, only VL from the Mcg light chain dimer (25) gave interpretable results. When the search models consisted of the entire LH asymmetric unit, the VL-VH pair, or the CL-CH1 pair extracted from the present IgGl structure, however, the predicted orientations accounted for the highest peaks in the maps. With the CH2-CH3 probe, the correct orientation was represented by the fourth highest peak.
In another test of the plausibility of the present structure, the locations of 35 sites occupied by heavy atoms in the MIR study (4) Fig.  2 with color-coded ,-pleated sheets. The molecule spans 148 A from tip to tip of the Fab arms (distance measured between the a-carbons of the two light chain serine-27 residues; Table 2 . Refinement protocol and statistics for data in Table 1 No. (25) were 174°and 1800 for the V pairs and 1700 and 1800 for the C pairs. Calculations for other Fabs clustered around these more common values.
In comparisons of quaternary structures, the five-stranded /3-pleated sheet of VL was found to face the corresponding sheet in VH, as in other immunoglobulins (see Fig. 2 which extends to the solvent space between the V and C domain pairs. Phenylalanine L98 interacts with tryptophan H47 at the beginning of the tunnel, but the remainder is not bridged by any side chains. On one side the tunnel is composed of residues identical to those lining the walls of the deep binding pocket (23) Unlike the V domains, CL and CH1 associate closely to produce a dimer with many (277) interdomain contacts, divided among 22 light and 18 heavy chain residues. Deviations from canonical pairing involve rigid-body shifts of both domains and conformational changes in individual segments. While CL and CH1 intersect at approximately the same angle as the CL domains of the light chain dimer (930 vs. 950), the predominant directions of the domains have changed in the IgGl. CL slants upward toward the second light chain and CH1 slopes downward toward the connector to CH2 (see Fig.  2 ). In a typical IgGl antibody, the hinge segment joined to CH1 forms a disulfide bond with the light chain and thus holds the ends of CH1 and CL in close proximity.
An additional alteration occurs in the orientation expected for CL. Using a light chain from the Mcg dimer as a canonical structure, we superimposed its VL on the VL in IgGl and then compared the CL domains. The center of mass of CL in the IgGl protein was found to be translated 15 A relative to its position in the light chain dimer. This translation was mediated mainly through the "switch region" between VL and CL.
Such extensive adjustments were made without seriously compromising the complementarity of CL with CHl.
CH1 is connected to the CH2 domain on the opposite side of the crystallographic twofold axis (a trans relation). A cis type of connectivity is incompatible with the electron density. Since the last residue (valine-H215) in CH1 remains associated with the globular part of the domain, the connector is derived exclusively from the CH2 sequence Ala-ProGlu-Leu-Leu-Gly-Gly. To avoid confusion, the residues are numbered 231-237 as in other antibodies. In functioning as a hinge by-pass, this heptapeptide segment assumes an almost fully extended conformation (23 A (42) . In rabbit Fc the carbohydrates are asymmetric in both sequence and structure (40) . Chemical analyses of Mcg samples used in crystallization trials gave nonintegral molar ratios for the monosaccharides, a strong indication of heterogeneity. In the molecules actually incorporated into crystals, however, the oligosaccharides are related by twofold symmetry, with its implied suggestion of homogeneity.
Instead of participating in interactions like those observed in the rabbit Fc (40), the a(1,3) carbohydrate arms (disaccharides of mannose and N-acetylglucosamine) in Mcg face each other across the midplane of the molecule without touching. The bridge sugar (N-acetylglucosamine) linked to asparagine H297 and the adjacent L-fucose residue remain close to the protein and interact with tyrosine-H296 and asparagine-H297. After the mannose core structure, the last three units in the a(1,6) branch (N-acetylglucosamine, galactose, and sialic acid) cross segments 1, 2, and 3 of the four-stranded ,-pleated sheet and weakly interact with the protein.
Functional Implications of the IgGl Structure. Although the natural antigen is unknown, the Mcg IgGl protein was found (43) Fig. 2 is compatible with the view (11) that the docking of complement component Clq is obstructed by the Fab arms in IgG proteins without hinge regions. A critical part of the docking site on CH2 includes glutamic acid-H318, lysine-H320, and lysine-H322 (20) . In Mcg this site is accessible from below, but the lateral approaches are restricted by the VL domains, and the access routes from above are blocked by CH1 from the opposite heavy chain.
Note that only one potential binding site for Clq is present on the "front" face of the molecule displayed in Fig. 2 . Since the symmetry-related site is sterically segregated on the "back" face, it is necessary to have two IgG molecules side by side to accommodate the minimal binding unit (two of six "heads") of Clq. This geometric arrangement probably explains why IgG antibodies have to be aggregated before they can activate the complement cascade.
As a consequence of the tilting of CH2 in Mcg, the space available for protein A binding at the CH2-CH3 junction is even larger than that in the Fc fragment (24) . For example, the distances between the a-carbons of methionine-H252 on CH2 and histidine-H435 on CH3 are 15.3 A in Mcg and 7.9 A in Fc.
The putative binding site for FcRI, centered around leucine-H235 (16, 17) in the hinge-bypass segment, is illustrated in Fig. 3 . Such an accessible, but semiprotected environment should meet the selectivity criteria for high-affinity binding to Fc receptors. As in Clq docking sites, the symmetry-related heptapeptide segments are located on different faces of the Mcg molecule and therefore can function as two independent sites for receptor attachment.
With viable ligand combining sites in the Fab arms and receptor attachment sites in the Fc region, the Mcg IgGl molecule seems to be a prototype for an unusual but not abnormal class of functional immunoglobulins. We prefer to consider it as a molecule representing one end of the enormously diverse set of antibodies that can be generated by the immune system.
